Neurocognitive Assessment System for the Elderly

Information

  • Research Project
  • 6796147
  • ApplicationId
    6796147
  • Core Project Number
    R44AG017397
  • Full Project Number
    5R44AG017397-04
  • Serial Number
    17397
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1999 - 25 years ago
  • Project End Date
    8/31/2007 - 17 years ago
  • Program Officer Name
    WAGSTER, MOLLY V.
  • Budget Start Date
    9/1/2004 - 20 years ago
  • Budget End Date
    8/31/2007 - 17 years ago
  • Fiscal Year
    2004
  • Support Year
    4
  • Suffix
  • Award Notice Date
    8/23/2004 - 20 years ago
Organizations

Neurocognitive Assessment System for the Elderly

DESCRIPTION (provided by applicant): Many medical treatments produce subtle changes in working and intermediate term memory and executive functioning in the elderly. Some medical treatments may have negative cognitive side effects, whereas other treatments improve cognitive function. Prior work demonstrates that combinations of EEG, event related potential and cognitive task performance data are sensitive and specific indicators of level of alertness and ability to sustain attention and hold information in working and intermediate term memory. We propose to develop a specialized automated device utilizing multivariate combinations of these measures to detect treatment related changes in neurocognitive function in the elderly. In Phase I feasibility was evaluated by analyzing task performance and EEG data from elderly subjects after they ingested a common OTC drug, the antihistamine diphenhydramine. We computed multivariate indices from these data, and determined that they could discriminate post-drug conditions from placebo. Additionally, we identified improvements required for use of our automated task presentation and signal processing algorithms with elderly subjects, and designed modifications to a system for administering, analyzing and tracking tests and results. In Phase II, the system will be fully implemented and independently tested in collaboration with scientists and clinicians at four university medical centers. PROPOSED COMMERCIAL APPLICATION: The proposed system will enable researchers to better evaluate how medical treatments affect neurocognitive function in the elderly. The market for such a device is sufficient to sustain the product. The system may also prove clinically useful as a means for titrating drug dosages and for tracking neurocognitive changes in the treatment of individual patients. Thus, a second-generation device may serve as a more general clinical tool for monitoring changes in cognitive status in the elderly. There is a large and rapidly growing market for such a clinical device.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R44
  • Administering IC
    AG
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    337567
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
    NIA:337567\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SAM TECHNOLOGY, INC.
  • Organization Department
  • Organization DUNS
    161157318
  • Organization City
    SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94117
  • Organization District
    UNITED STATES